Acute Myeloid Leukemia With RUNX1::RUNX1T1 Fusion Transformed From JAK2V617F-Mutated Polycythemia Vera: A Case Report

由JAK2V617F突变型真性红细胞增多症转化而来的RUNX1::RUNX1T1融合型急性髓系白血病:病例报告

阅读:2

Abstract

Leukemic transformation is an event that significantly affects the prognosis of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs). In acute myeloid leukemia (AML) transformed from MPNs, balanced chromosomal translocations, including t(8;21)(q22;q22.1), are extremely rare. A case of secondary AML with RUNX1::RUNX1T1 fusion that evolved from polycythemia vera (PV) is presented. An 87-year-old Japanese man was diagnosed with PV 22 years earlier and had been treated with hydroxyurea and aspirin. Twelve years earlier, a homozygous JAK2V617F mutation was identified. Regular blood tests conducted every four months showed leukocytosis (white blood cell count, 14.6 × 10(9)/L), anemia (hemoglobin, 106 g/L), and thrombocytopenia (platelet count, 73 × 10(9)/L). Of the white blood cells, 5.5% were blasts, and the pseudo-Pelger-Huët anomaly and degranulated neutrophils were also observed. Bone marrow aspiration showed 18.2% myeloblasts with varying morphology, characterized by basophilic cytoplasm and wide cytoplasm containing numerous azurophilic granules and perinuclear hofs. The appearance of neutrophils with pink-colored cytoplasm was also noted. Flow cytometry (FCM) showed positivity for myeloid markers, as well as CD34 and CD19, and myeloperoxidase was strongly positive. Morphological findings and FCM results were highly suggestive of AML with the RUNX1::RUNX1T1 fusion gene. Chromosomal analysis identified a translocation t(8;21)(q22;q22.1), and the real-time quantitative polymerase chain reaction detected the RUNX1::RUNX1T1 fusion gene. Based on these findings, the patient was diagnosed with AML with RUNX1::RUNX1T1 fusion that had transformed from PV. In addition, the JAK2V617F mutation (homozygous) was detected in peripheral blood at the time of transformation to AML. Leukemic evolution from MPNs often involves morphological changes in addition to genetic and chromosomal abnormalities. Therefore, during the follow-up of MPN, it is important to focus on changes in the blood cell morphology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。